Transient Ischemic Attack

Clinical Trial Finder

Many patients who experience transient ischemic attacks (TIAs) are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Tranexamic Acid in Revision Total Joint Arthroplasty

Conditions:   Revision Total Knee Arthroplasty;   Revision Total Hip Arthroplasty;   Acute Blood Loss Anemia
Interventions:   Procedure: Revision Total Knee Arthroplasty (TKA);   Procedure: Revision Total Hip Arthroplasty (THA)
Sponsors:   Rush University Medical Center;   Mayo Clinic
Recruiting - verified August 2016

Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"

Condition:   Thrombosis
Interventions:   Drug: BMS-986141;   Drug: Aspirin;   Other: Placebo
Sponsor:   Bristol-Myers Squibb
Recruiting - verified July 2016

Study of the Performance of Stroke Management in the Rhône Area

Condition:   Stroke
Sponsor:   Hospices Civils de Lyon
Recruiting - verified August 2016

The Peregrine Post-Market Study for the Treatment of Hypertension

Condition:   Hypertension
Intervention:   Device: Peregrine System Infusion Catheter
Sponsor:   Ablative Solutions, Inc.
Recruiting - verified August 2016

Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)

Condition:   Venous Thromboembolism
Intervention:   Drug: Rivaroxaban (Xarelto, BAY59-7939)
Sponsor:   Bayer
Recruiting - verified August 2016

A Predictive Score for the Ischemic Etiology of a Transient Visual Disturbances (VASCO)

Condition:   Vision Disorders
Intervention:   Other: Clinical, ophthalmological and neurological evaluation
Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild
Recruiting - verified August 2016

Sequential Expansion of Comparative Effectiveness of Anticoagulants

Condition:   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified August 2016

Vascular Inflammation Imaging Using Somatostatin Receptor Positron Emission Tomography

Conditions:   Atherosclerosis;   Stroke;   Transient Ischemic Attack;   Chronic Stable Angina;   Acute Coronary Syndrome
Sponsor:   University of Cambridge
Completed - verified August 2016

Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)

Conditions:   Ischemic Stroke;   Atrial Fibrillation;   Transient Ischemic Attacks;   Transient Cerebrovascular Events;   Thrombotic Stroke;   Stroke of Basilar Artery;   Cardioembolic Stroke
Intervention:   Other: Biomarker blood draw
Sponsor:   Ischemia Care LLC
Recruiting - verified August 2016

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease

Condition:   Prevention &Amp; Control
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin;   Drug: Aspirin placebo;   Drug: Rivaroxaban placebo;   Drug: Pantoprazole
Sponsors:   Bayer;   Hamilton Health Sciences Corporation, Population Health Research Institute
Recruiting - verified August 2016

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified August 2016

A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease

Condition:   Crohn's Disease
Interventions:   Drug: CP-690,550;   Drug: CP-690,550
Sponsor:   Pfizer
Completed - verified August 2016